Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06270836
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-02-14
Brief Title:
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy NPDR
Sponsor:
Kodiak Sciences Inc
Organization:
Kodiak Sciences Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-proliferative Diabetic Retinopathy |
Keywords:
| Name | View |
|---|---|
| NPDR | View |
| Diabetic Retinopathy | View |
| Tarcocimab | View |
| KSI-301 | View |
| VEGF | View |
| Anti-VEGF | View |
| Vascular Endothelial Growth Factor | View |
| Antibody Biopolymer Conjugate | View |
| Retinal Degeneration | View |
| Retinal Diseases | View |
| Eye Diseases | View |
| Retinopathy | View |
| Vision Disorders | View |
| Kodiak | View |
| Tarcocimab Tedromer | View |